Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.319ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.319NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.182ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.182ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.182ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.182NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.430ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.430ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.430ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.430NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.331ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.331ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.331ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.331NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-11307.3China
B.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-13571.9China
B.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
AY.112.3 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.112.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.112.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.112.3 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.515ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.515ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.515ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.515NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.287ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.287ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.287ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.287NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.431ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.431ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.431ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.431NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.170ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.170ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.170ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.170NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used